The compound is called cannabizetol (CBGD), and it’s only the fourth dimeric cannabinoid ever identified in cannabis. When researchers tested it against 84 different inflammatory genes, it showed significantly higher anti-inflammatory activity than any previously studied dimeric cannabinoid. It works through the NF-κB pathway—essentially a master switch for inflammation throughout the human body—and exhibits powerful antioxidant properties that could have applications in dermatology, chronic inflammation, and potentially dozens of other medical conditions we haven’t even imagined yet.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…